Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schulman

Showing results (111-120 of 240) with videos related to

Pageof 24
Sort By:
Medicine|January 22, 2008
Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trialsJoel B Braunstein, Noëlle S Sherber, Steven P Schulman, et al.
Archives of Internal Medicine|March 1, 1981
Pancytopenia complicating Graves' disease and drug-induced hypothyroidismA L Talansky, P Schulman, V P Vinciguerra, et al.
Cancer Treatment Reports|July 1, 1984
Phase I trial of vinzolidineD R Budman, P Schulman, M Marks, et al.
CA: a Cancer Journal for Clinicians|May 1, 1980
Home Oncology Medical Extension: a new home treatment programV Vinciguerra, T Degnan, J Diener, et al.
Circulation|April 1, 2009
Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy studyPaul A Bottomley, Katherine C Wu, Gary Gerstenblith, et al.
Contemporary Clinical Trials|November 25, 2017
Effect of intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention: Design, rationale, and sample characteristics of the PACIFY randomized trialKhalil Ibrahim, Rakesh R Goli, Rohan Shah, et al.
Pediatric Cardiology|January 5, 2008
Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutationsAisha Frazier, Daniel P Judge, Steven P Schulman, et al.
Circulation|May 16, 2000
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 yearsD R Thiemann, J Coresh, S P Schulman, et al.
The American Journal of Physiology|December 1, 1992
Age-related decline in left ventricular filling at rest and exerciseS P Schulman, E G Lakatta, J L Fleg, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Using Machine Learning for Early Prediction of Cardiogenic Shock in Patients With Acute Heart FailureFaisal Rahman, Noam Finkelstein, Anton Alyakin, et al.
Pageof 24

Showing results (111-120 of 240) with videos related to

Sort By:
Pageof 24
Medicine|January 22, 2008
Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trialsJoel B Braunstein, Noëlle S Sherber, Steven P Schulman, et al.
Archives of Internal Medicine|March 1, 1981
Pancytopenia complicating Graves' disease and drug-induced hypothyroidismA L Talansky, P Schulman, V P Vinciguerra, et al.
Cancer Treatment Reports|July 1, 1984
Phase I trial of vinzolidineD R Budman, P Schulman, M Marks, et al.
CA: a Cancer Journal for Clinicians|May 1, 1980
Home Oncology Medical Extension: a new home treatment programV Vinciguerra, T Degnan, J Diener, et al.
Circulation|April 1, 2009
Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy studyPaul A Bottomley, Katherine C Wu, Gary Gerstenblith, et al.
Contemporary Clinical Trials|November 25, 2017
Effect of intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention: Design, rationale, and sample characteristics of the PACIFY randomized trialKhalil Ibrahim, Rakesh R Goli, Rohan Shah, et al.
Pediatric Cardiology|January 5, 2008
Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutationsAisha Frazier, Daniel P Judge, Steven P Schulman, et al.
Circulation|May 16, 2000
Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 yearsD R Thiemann, J Coresh, S P Schulman, et al.
The American Journal of Physiology|December 1, 1992
Age-related decline in left ventricular filling at rest and exerciseS P Schulman, E G Lakatta, J L Fleg, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Using Machine Learning for Early Prediction of Cardiogenic Shock in Patients With Acute Heart FailureFaisal Rahman, Noam Finkelstein, Anton Alyakin, et al.
Pageof 24